Stoke Therapeutics, Inc. (STOK)
28.49
-0.88
(-3.00%)
USD |
NASDAQ |
Jun 10, 16:00
28.49
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics EPS Diluted (TTM) : -2.842 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -2.842 |
| December 31, 2025 | -0.1485 |
| September 30, 2025 | 0.6599 |
| June 30, 2025 | 0.8451 |
| March 31, 2025 | 0.7867 |
| December 31, 2024 | -1.684 |
| September 30, 2024 | -2.100 |
| June 30, 2024 | -2.185 |
| March 31, 2024 | -2.418 |
| December 31, 2023 | -2.378 |
| September 30, 2023 | -2.429 |
| June 30, 2023 | -2.537 |
| March 31, 2023 | -2.471 |
| December 31, 2022 | -2.599 |
| September 30, 2022 | -2.612 |
| June 30, 2022 | -2.564 |
| March 31, 2022 | -2.535 |
| Date | Value |
|---|---|
| December 31, 2021 | -2.335 |
| September 30, 2021 | -2.091 |
| June 30, 2021 | -1.888 |
| March 31, 2021 | -1.682 |
| December 31, 2020 | -1.559 |
| September 30, 2020 | -1.449 |
| June 30, 2020 | -1.301 |
| March 31, 2020 | -2.447 |
| December 31, 2019 | -2.287 |
| September 30, 2019 | -2.108 |
| June 30, 2019 | -1.946 |
| March 31, 2019 | -0.5005 |
| December 31, 2018 | -0.3832 |
| September 30, 2018 | -0.2522 |
| June 30, 2018 | -0.1507 |
| March 31, 2018 | -0.0586 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | -1.202 |
| Agenus, Inc. | 1.670 |
| Amgen, Inc. | 14.38 |
| BioCryst Pharmaceuticals, Inc. | -1.776 |
| Imunon, Inc. | -5.167 |